Cellectis (CLLS) Net Margin Growth (3y) (2018 - 2026)
Cellectis (CLLS) Net Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cellectis |
17.40 Bn |
17.21 Bn |
- |
2.15 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
2.15 Mn |
| Dec 31, 2025 |
-3,962.00 |
| Sep 30, 2025 |
1.63 Mn |
| Jun 30, 2025 |
130,766.00 |
| Mar 31, 2025 |
174,644.00 |
| Dec 31, 2024 |
27,258.00 |
| Sep 30, 2024 |
30,779.00 |
| Jun 30, 2024 |
4,370.00 |
| Mar 31, 2024 |
17,098.00 |
| Dec 31, 2023 |
-1.45 Mn |
| Sep 30, 2023 |
-1.08 Mn |
| Jun 30, 2023 |
-546,445.00 |
| Mar 31, 2023 |
-2.17 Mn |
| Dec 31, 2022 |
67,394.00 |
| Sep 30, 2022 |
-1.61 Mn |
| Jun 30, 2022 |
145,381.00 |
| Mar 31, 2022 |
-44,476.00 |
| Dec 31, 2021 |
214,019.00 |
| Sep 30, 2021 |
206,700.00 |
| Jun 30, 2021 |
-27,021.00 |
